Your RCM Impact Analysis

YOUR PRACTICE

Tell us about your current state

Number of providers 12

150100150+

Specialty Orthopedic

Default charges/provider $2.2M

Current Net Collection Rate 92%

80%MGMA 95%Top 98%

MGMA benchmark 95% · Medusind avg 98%+

Current Days in A/R 55 days

20MGMA 406090+

MGMA benchmark < 40 days · Medusind target ~32 days

Advanced — override specialty defaults ▼

Avg. gross charges per provider $2.20M

$300K$2M$4M+

Contractual adjustment rate 42%

20%40%60%

% of gross charges written off per payor contracts

PROJECTED IMPACT

What Medusind could recover

3-Year Total Financial Impact

Combines recurring annual revenue lift plus one-time working-capital release from A/R acceleration, based on your practice reaching Medusind's top-quartile benchmarks.

Annual Revenue Uplift

Recurring, year after year

Cash Released from A/R

One-time working capital gain

Current vs. Medusind-optimized performance

You today

With Medusind

See the specialty-specific path to these numbers.

In a 30-minute working session, we'll walk through your actual payor mix, denial patterns, and coding workflow — and quantify which of these gains are achievable in the first 90 days.

Book a 30-min working session →

How we calculate this

Transparent math. No black boxes. Audit-ready for your CFO.

Annual Revenue Uplift (the recurring number)

The core formula is simple and transparent:

Collectible Charges × (Target NCR − Your Current NCR)

Where:

Collectible Charges = Gross Charges × (1 − Contractual Adjustment %)
Gross Charges = Providers × specialty-average charges per provider (adjustable in Advanced)
Target NCR = 98% — the average of Medusind's active client book, consistent with MGMA top-quartile performance. Your Current NCR is the slider value.

This is a conservative approach: it assumes no increase in charge capture, no payor contract renegotiation, and no improvement in patient collections — all of which typically add to the uplift.

Cash Released from A/R (the one-time number)

Bringing Days in A/R from your current level down to the Medusind target (~32 days) releases working capital that was previously tied up in unpaid claims.

(Current A/R Balance) − (Optimized A/R Balance)

Where A/R Balance = (Annualized Collections ÷ 365) × Days in A/R.

This is a one-time gain — the balance sheet improvement from accelerating collections. After that, your faster cash cycle is a permanent operational advantage.

Benchmarks & sources

MGMA Net Collection Rate benchmark: 95% (multi-specialty median); 98% top-quartile for groups of 20+ providers
MGMA Days in A/R benchmark: < 40 days; top performers under 30
Industry denial rate: 10–12% trending upward (2025 MGMA data); best-in-class under 5%
A/R > 90 days benchmark: MGMA range 12–15% of total A/R
Medusind client average: 98%+ NCR, 30% improvement in patient collections, 20% A/R improvement (based on active book of business)

Sources: MGMA DataDive 2024–2025, HFMA MAP Keys, Medusind client portfolio metrics.

What's NOT included (conservative framing)

We deliberately exclude several real sources of value to keep this model defensible:

Clean claim rate improvements that reduce re-work hours
Staff cost avoidance from eliminating in-house billing FTE
Patient collection improvements (our clients typically see ~30% lift here)
Coding optimization that increases charge capture per encounter
Credentialing acceleration that reduces provider ramp time to first claim

We'll model these in a working session tailored to your practice.

What we'd need from you to refine this

12 months of charges, adjustments, and collections by payor
Current A/R aging buckets (0–30, 31–60, 61–90, 91+)
Denial volume and top denial reason codes
Payor mix percentages
Your current PMS/EHR (Medusind supports 70+ systems — no migration required)

This is exactly what we'll cover in the working session.